Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1813-1823

  Rattanasompattikul, Manoch ^a   Feroze, Usama ^a   Molnar, Miklos Z ^a,b   Dukkipati, Ramanath ^a,c   Kovesdy, Csaba P ^d,e   Nissenson, Allen R ^c,f   Norris, Keith C ^c   Kopple, Joel D ^a,c   Kalantar Zadeh, Kamyar ^a,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f DAVITA INC   (United States)

Author keywords

Charlson Comorbidity Index; Chronic Kidney Disease (CKD); Hemodialysis; Inflammation; Survival

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AFRICAN AMERICAN; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; PREDICTION; RISK ASSESSMENT; SURVIVAL RATE; AGED; CHRONIC KIDNEY FAILURE; MIDDLE AGED; PROGNOSIS; RENAL REPLACEMENT THERAPY;

AGED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS;

EID: 84877599353     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0085-9     Document Type: Article

References (41)

1. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2009) United States Renal Data System 2008 annual data report. Am J Kidney Dis 53:S1-374
2. Khan IH (1998) Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transpl 13(suppl 1):76-79
3. van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT (2002) How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 40:82-89
4. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM (1993) Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341:415-418
5. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K (1999) Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (Clin Res Ed) 318:217-223
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
7. Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, Schmid CH, Greenfield S, Levey AS, Meyer KB (2000) Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial 13:320-326
8. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI (1995) Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 26:353-361
9. Hall SF (2006) A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol 59:849-855
10. Fried L, Bernardini J, Piraino B (2001) Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37:337-342
11. Di Iorio B, Cillo N, Cirillo M, De Santo NG (2004) Charlson comorbidity index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization. Int J Artif Organs 27:330-336
12. Colman S, Bross R, Benner D, Chow J, Braglia A, Arzaghi J, Dennis J, Martinez L, Baldo DB, Agarwal V, Trundnowski T, Zitterkoph J, Martinez B, Khawar OS, Kalantar-Zadeh K (2005) The nutritional and inflammatory evaluation in dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr 15:231-243
13. Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A, Noori N, Jing J, Kovesdy CP, Kalantar-Zadeh K (2010) Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 31:419-425
14. Noori N, Kopple JD, Kovesdy CP, Feroze U, Sim JJ, Murali SB, Luna A, Gomez M, Luna C, Bross R, Nissenson AR, Kalantar-Zadeh K (2010) Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5:2258-2268
15. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD (2010) Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 5:683-692
16. Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD (2010) Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 56:338-347
17. Raj DS, Shah VO, Rambod M, Kovesdy CP, Kalantar-Zadeh K (2009) Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis 54:1062-1071
18. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K, Nissenson A (2007) Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 18:2781-2788
19. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML (2000) A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108:609-613
20. Nelson EE, Hong CD, Pesce AL, Peterson DW, Singh S, Pollak VE (1990) Anthropometric norms for the dialysis population. Am J Kidney Dis 16:32-37
21. Williams AJ, McArley A (1999) Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 9:157-162
22. Kalantar-Zadeh K, Dunne E, Nixon K, Kahn K, Lee GH, Kleiner M, Luft FC (1999) Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transpl 14:169-175
23. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD (2006) Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83:202-210
24. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565
25. Erbagci AB, Tarakcioglu M, Aksoy M, Kocabas R, Nacak M, Aynacioglu AS, Sivrikoz C (2002) Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 57:197-204
26. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transpl 17:1684-1688
27. Beutler B, Cerami A (1989) The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 7:625-655
28. Keane WF, Collins AJ (1994) Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24:1010-1018
29. Wright LF (1991) Survival in patients with end-stage renal disease. Am J Kidney Dis 17:25-28
30. Heller DA, Ahern FM, Pringle KE, Brown TV (2009) Among older adults, the responsiveness of self-rated health to changes in Charlson comorbidity was moderated by age and baseline comorbidity. J Clin Epidemiol 62:177-187
31. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP (2008) The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 61:1234-1240
32. Zavascki AP, Fuchs SC (2007) The need for reappraisal of AIDS score weight of Charlson comorbidity index. J Clin Epidemiol 60:867-868
33. Nuttall M, van der Meulen J, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59:265-273
34. Miskulin DC, Martin AA, Brown R, Fink NE, Coresh J, Powe NR, Zager PG, Meyer KB, Levey AS (2004) Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transpl 19:413-420
35. Hopman WM, Harrison MB, Coo H, Friedberg E, Buchanan M, VanDenKerkhof EG (2009) Associations between chronic disease, age and physical and mental health status. Chronic Dis Can 29:108-116
36. System United States Renal Data (2007) United States renal data system 2006 annual data report atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 49:1-296
37. United States Renal Data System (2006) Excerpts from the USRDS 2005 annual data report: atlas of end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kid Dis 47(suppl 1):1-286
38. Agodoa L, Norris K, Pugsley D (2005) The disproportionate burden of kidney disease in those who can least afford it. Kidney Int Suppl 97:S1-S3
39. Hsu CY, Lin F, Vittinghoff E, Shlipak MG (2003) Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14:2902-2907
40. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ (2007) Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 18:1299-1306
41. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S (2005) Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transpl 20:1880-1888